Toggle navigation
TWunroll
TWunroll
faq
Contact US
Charlie White
c_write
Vaxart said its Phase 1 trial vaccine candidate -- a tablet that's stable at room temperature, not a shot -- sparked T-cell responses that were higher than those seen in
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree